SCHEMBL8282835

SCHEMBL8282835

CCc1csc(C2(NC[C@@H](O)CCc3cc(F)cc(F)c3)CCCCC2)c1

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.64
CTSD P07339 12/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8283519 0.87 BACE1 (0.48) BACE1CTSD
SCHEMBL8281560 0.87 BACE1 (0.64) BACE1CTSD
SCHEMBL8281846 0.85 BACE1 (0.49) BACE1CTSD
SCHEMBL8282555 0.84 BACE1 (0.64) BACE1CTSD
SCHEMBL8283445 0.82 BACE1 (0.48) BACE1CTSD
SCHEMBL2873462 0.82 BACE1 (0.48) BACE1CTSD
SCHEMBL8282610 0.82 BACE1 (0.51) BACE1CTSD
SCHEMBL8281826 0.81 BACE1 (0.61) BACE1CTSD
SCHEMBL2879615 0.78 BACE1 (0.64) BACE1CTSD
SCHEMBL8281521 0.78 BACE1 (0.64) BACE1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005070407-A1 METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2005-08-04 WO disclosed